Study of RNS60 on Pain and Function After Hip Labral Repair

Sponsor
Revalesio Corporation (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT02005523
Collaborator
(none)
0
1
2

Study Details

Study Description

Brief Summary

The purpose of this study is to see if use of RNS60 during hip labral repair surgery decreases pain and improves functional capacity post-operation.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Hip Labral Repair or Reconstruction Surgery
Actual Primary Completion Date :
Oct 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: RNS60

Drug: RNS60

Placebo Comparator: Saline

Drug: Saline

Outcome Measures

Primary Outcome Measures

  1. Assessment of post-operative pain [1 week]

    Comparison of scores from validated pain scales from post-surgery to one week.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tacoma Washington United States

Sponsors and Collaborators

  • Revalesio Corporation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Revalesio Corporation
ClinicalTrials.gov Identifier:
NCT02005523
Other Study ID Numbers:
  • 07.1.1.H2
First Posted:
Dec 9, 2013
Last Update Posted:
Feb 6, 2015
Last Verified:
Feb 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 6, 2015